News for Healthier Living

RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy

About half of all patients with advanced melanoma face a poor prognosis because their cancer doesn't respond to immunotherapy -- but results of a recent clinical trial show that an unusual treatment strategy could change that.

August 18, 2025


September 2 2025

September 1 2025

August 31 2025

August 30 2025

August 29 2025

August 28 2025

August 27 2025

August 26 2025

August 25 2025

August 24 2025

August 23 2025

August 22 2025

August 21 2025

August 20 2025